Metastatic Disease Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
MRKR | D | Marker Therapeutics, Inc. | -6.27 | |
CLDI | C | Calidi Biotherapeutics, Inc. | -3.49 |
Related Industries: Biotechnology
Compare ETFs
Date | Stock | Title |
---|---|---|
Nov 17 | MRKR | Marker Therapeutics Third Quarter 2024 Earnings: Beats Expectations |
Nov 14 | MRKR | Marker Therapeutics GAAP EPS of -$0.26, revenue of $1.93M |
Related Industries:
Biotechnology
- Metastatic Disease
Popular Now
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles